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Xk-Related Protein 8 and CED-8
Promote Phosphatidylserine
Exposure in Apoptotic Cells
Jun Suzuki,1 Daniel P. Denning,2 Eiichi Imanishi,1 H. Robert Horvitz,2 Shigekazu Nagata1,3*
A classic feature of apoptotic cells is the cell-surface exposure of phosphatidylserine (PtdSer)
as an “eat me” signal for engulfment. We show that the Xk-family protein Xkr8 mediates PtdSer
exposure in response to apoptotic stimuli. Mouse Xkr8−/− cells or human cancer cells in which
Xkr8 expression was repressed by hypermethylation failed to expose PtdSer during apoptosis and
were inefficiently engulfed by phagocytes. Xkr8 was activated directly by caspases and required
a caspase-3 cleavage site for its function. CED-8, the only Caenorhabditis elegans Xk-family
homolog, also promoted apoptotic PtdSer exposure and cell-corpse engulfment. Thus, Xk-family
proteins have evolutionarily conserved roles in promoting the phagocytosis of dying cells by
altering the phospholipid distribution in the plasma membrane.
Phospholipids are distributed asymmetrical-ly between the outer and inner leaflets ofplasma membranes (1): Phosphatidylserine
(PtdSer) and phosphatidylethanolamine (PtdEtn)
localize exclusively to the inner leaflet, whereas
60 to 70% of phosphatidylcholine (PtdCho) and
sphingomyelin (SM) are found on the outer leaf-
let. This asymmetric distribution is disrupted dur-
ing apoptosis, and exposed PtdSer on dying cells
serves as an “eat me” signal to facilitate phago-
cytosis (2, 3). PtdSer exposure and the more gen-
eral transfer of phospholipids between the inner
and outer leaflets are probably mediated by phos-
pholipid scramblases (1), the identities of which
are disputed (4).
We previously generated a mouse Ba/F3 pro-
B cell line (Ba/F3-PS19)with a high level of PtdSer
exposure, constructed a cDNA library (of clones
>2.5 kb), and discovered TMEM16F, a transmem-
brane protein required for Ca2+-dependent phos-
pholipid scrambling but not apoptosis-dependent
PtdSer exposure (5, 6). To identifymolecules that
mediate apoptotic PtdSer exposure, we introduced
aBa/F3-PS19 cDNA library (of clones 1.0 to 2.5 kb)
into Ba/F3 cells, serially enriched for cells with
high PtdSer exposure, and established a cell line
(LD-PS5-2-2) with a high level of PtdSer expo-
sure (Fig. 1A) (see supplementary materials and
methods). LD-PS5-2-2 cells carried a cDNA en-
coding Xkr8, a member of the evolutionarily con-
served XK protein family (7) (figs. S1 and S2).
With the use of the programs Transmembrane
Prediction (www.ch.embnet.org) and Transmem-
brane Hidden Markov Model (www.cbs.dtu.dk),
analyses of the amino acid sequences of verte-
brate Xkr8 orthologs suggested that Xkr8 contains
six transmembrane regions flanked by cytosolic
N and C termini (fig. S3).
We transformedmouseTcell lymphomaWR19L
cells with Fas (8) (WR-Fas). Fas ligand (FasL)
efficiently induced apoptosis of theWR-Fas cells,
accompanied by caspase-3 activation and PtdSer
exposure (Fig. 1B and fig. S4). The introduction
of mouse Xkr8-GFP [mXkr8 fused to green fluo-
rescent protein (GFP)], but not mTMEM16F-
GFP, increased the fraction of PtdSer-exposing
cells generated by FasL (Fig. 1B). The expres-
sion of mXkr8 short hairpin RNAs (shRNAs) in
WR-Fas cells decreased the amount of the en-
dogenous mXkr8 mRNA by 76 to 82% (fig. S5)
and the fraction of cells with FasL-induced PdtSer-
exposure (Fig. 1C), but not levels of caspase-3
activation (fig. S5). The transformation of mXkr8
shRNA-expressing cellswith human (h)Xkr8 cDNA,
which is not recognized by the mXkr8 shRNAs,
restored FasL-induced PdtSer exposure. hXkr8-
GFP expressed in human 293T cells localized
primarily to the plasma membrane (Fig. 1D), sug-
gesting that Xkr8 functions at the cell surface to
promote apoptotic PtdSer exposure.
Human PLB-985 leukemia and Raji lympho-
ma cells do not expose PtdSer during apoptosis
(9, 10). Studies using real-time reverse transcrip-
tion polymerase chain reaction (RT-PCR) indi-
cated that the amount of Xkr8mRNA in PLB-985
and Raji cells was 8 and 9%, respectively, of
those in Namalwa cells (Fig. 2A). PLB-985 or
Raji cell transformants expressing hXkr8 re-
sponded to apoptotic stimuli by exposing PtdSer
(Fig. 2B). PtdSer exposure is necessary for the
recognition of apoptotic cells by phagocytes
1Department of Medical Chemistry, Graduate School of Medicine,
Kyoto University, Yoshida-Konoe, Sakyo-ku, Kyoto, Kyoto 606-
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Fig. 1. Xkr8-mediated PtdSer exposure. (A) Staining of Ba/F3 and
LD-PS5-2-2 cells with Cy5–Annexin V. (B) WR-Fas cells and transformants
expressing mXkr8-GFP or mTMEM16F-GFP were treated with FasL and
stained with Cy5-Annexin V. (C) WR-Fas cells transformed with scrambled
shRNA,mXkr8 shRNA, or bothmXkr8 shRNA and hXkr8 cDNA were treated
with FasL and stained with Cy5-Annexin V. Representative fluorescence-
activated cell sorting (FACS) profiles for each group are shown. (D) 293T
cells expressing hXkr8-GFP were observed by fluorescence microscopy.
Scale bar, 10 mm.
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(3, 10, 11). Accordingly, whereas apoptotic PLB-
985 cells were rarely engulfed by macrophages,
their Xkr8 transformants were frequently internal-
ized (Fig. 2C). Caspase-3 activation, DNA frag-
mentation, cell death, and cell shrinkage occurred
similarly in PLB-985 cells with or without Xkr8
expression, indicating that Xkr8 and PtdSer ex-
posure had no obvious effects on other aspects of
the apoptotic process (fig. S6). The program
CpG Island Searcher (http://cpgislands.usc.edu)
identified two CpG islands near the transcrip-
tion start site of the hXkr8 gene (fig. S7). Bi-
sulfite DNA sequencing (12) indicated that none
of the 23 CpGs between –232 and +4 of the
hXkr8 gene was methylated in peripheral blood
leukocyte, Jurkat, or Namalwa cells (fig. S7). By
contrast, these CpGs were methylated with more
than 90% probability in PLB-985 and Raji
cells. Treatment of PLB-985 cells with 5-aza-2′-
deoxycytidine (DAC) increased Xkr8 mRNA
levels (Fig. 2D). After 7 days of DAC treatment,
all CpGs were demethylated (fig. S7), and Xkr8
mRNA levels were 91% of that in Namalwa
cells. Accordingly, DAC-treated PLB-985 cells
exposed PtdSer upon ultraviolet (UV) irradiation
(Fig. 2E). We suggest that the methylation of
CpG islands in the Xkr8 promoter in PLB-985
and Raji cells blocks Xkr8 gene expression and
prevents apoptotic PtdSer exposure.
We used RO09-0198 to assay staurosporine-
treated, Xkr8-expressing PLB-985 cells for PtdEtn
exposure, and we used 1-oleoyl-2-{6-[(7-nitro-
2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-
sn-glycero-3-phosphocholine (NBD-PC) and
NBD-sphingosine-1-phosphocholine (NBD-SM)
to assay for PtdCho and SM internalization, re-
spectively. Inhibitor of caspase-activated DNase
(ICAD) was cleaved equally well in PLB-985 and
its hXkr8 transformants after staurosporine treat-
ment (fig. S8). By contrast, apoptotic hXkr8-
expressing cells (but not parental cells) stained
with RO09-0198 and internalized NBD-PC and
NBD-SM (fig. S8), indicating that Xkr8, like
TMEM16F (5), promotes the scrambling of mul-
tiple lipid species. Unlike TMEM16F, Xkr8 had
no effect on the Ca2+-induced exposure of PtdSer
(fig. S9), suggesting that distinct pathways con-
trol Ca2+-induced phospholipid scrambling and
apoptosis-induced scrambling. These findings are
consistent with reports that B cell lines from Scott
syndrome patients, who carry a null mutation in
TMEM16F, respond to apoptotic stimuli by ex-
posing PtdSer (13), and that mouse Bak−/−Bax−/−
platelets, which do not undergo apoptosis, ex-
pose PtdSer upon Ca2+ ionophore treatment (14).
We used the programCASVM (www.casbase.
org) to analyze Xkr8 sequences from six verte-
brates and, thus, identify a conserved caspase-3–
recognition site near theXkr8 C terminus (fig. S1).
We generated a mutant version of hXkr8 (2DA)
inwhich the putative caspase-recognition sequence
at position 355 was changed from PDQVDG to
PAQVAG (P, Pro; D, Asp; Q, Gln; V, Val; G, Gly;
A, Ala) (fig. S3). PLB-985 cells expressing wild-
type (WT) hXkr8-GFP exposed PtdSer in response
to staurosporine (Fig. 3A), accompanied by the
loss of a 52-kD hXkr8-GFP band on polyacryl-
amide gels and the appearance of a 29-kD band
detected with antibodies to GFP (anti-GFP) (Fig.
3B). After staurosporine treatment, hXkr8(2DA)-
GFP failed to promote PtdSer exposure and was
not proteolytically processed; ICAD was cleaved
in cells expressing either the WT or 2DA mutant
of hXkr8, indicating similar caspase-3 activity in
both cell lines. Processing of mXkr8-GFP at the
caspase-recognition site during apoptosis was also
observed in WR-Fas cells after treatment with
FasL (Fig. 3C). The solubilized membrane frac-
tion from cells expressing hXkr8-GFP was then
incubated with human caspases. Western blot anal-
ysis with anti-GFP showed that caspases-3 and
-7 cleaved the WT but not 2DA mutant hXkr8
(Fig. 3D). Thus, mammalian Xkr8 is activated to
expose PtdSer via caspase-mediated cleavage of
its cytosolic C terminus.
Mouse Xkr8 mRNA was detectable in most
mouse tissues (fig. S10), with notably high ex-
pression in the testes. We established mXkr8-
conditional knockoutmice (fig. S11), fromwhich
we preparedmouse embryonic fibroblasts (MEFs).
After treatment with staurosporine, Xkr8+/− but
not Xkr8−/−MEFs exposed PtdSer (Fig. 4A). Sim-
ilarly,Xkr8 flox/flox andTMEM16F −/−but notXkr8−/−
fetal thymocyte (IFET) cell lines exposed PtdSer
in response to FasL (Fig. 4B), although caspase-3
was activated similarly in these cell lines (fig. S12).
The transformation of Xkr8−/− IFETs with mXkr8
restored PtdSer exposure in response to FasL.
The protein CED-8 is the onlyCaenorhabditis
elegans homolog of Xk proteins and was pre-
viously shown to control the timing of programmed
cell deaths (15) (fig. S2). To determine if CED-8
(like Xkr8) promotes phagocytosis, we examined
ced-8 eggs for “floater” cells, which are gener-
ated in embryos defective in engulfment; floaters
are a subset of apoptotic cells that, if not engulfed
(e.g., in ced-1, -2, -5, -6, -7, -10, or -12mutants),
detach from the embryo (Fig. 4C and fig. S13)
(16, 17). ced-8 eggs contained floaters, and ced-8
mutations synergistically enhanced the number of
floaters inmutants partially defective in engulfment.
Fig. 2. Epigenetic repression of Xkr8 in human cancer cell lines. (A) Abundance of hXkr8 mRNA
relative to b-actin mRNA was determined by real-time RT-PCR. (B) The indicated cell lines and hXkr8
transformants were treated with apoptotic stimuli and stained with Cy5–Annexin V. STS, staurosporine. (C)
PLB-985 cells and hXkr8 transformants were treated with UV, labeled with pHrodo, and incubated with
CD11b+ peritoneal macrophages. (Left) FACS profiles for pHrodo-positive CD11b+ cells are shown, as is the
average percentage of pHrodo+ cells from three experiments. (Right) Macrophages (arrowheads) engulfing
apoptotic cell were observed by fluorescence microscopy. (D) PLB-985 cells were treated with DAC, and
Xkr8 mRNA was quantified relative to GADPH mRNA by real-time RT-PCR. DMSO, dimethyl sulfoxide. (E)
PLB-985 cells were treated with DAC for 5 days, exposed to UV, and stained with Cy5–Annexin V and
propidium iodide.
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This enhancement was dependent on the caspase
gene ced-3 (fig. S14), which is required for apoptosis.
The PtdSer-binding protein MFG-e8::Venus (18)
associated with 94% of apoptotic cell corpses in
the ventral cords of WT animals, but only with
21% of those in ced-8mutants (Fig. 4D). Similarly,
PtdSer was exposed on newly detached floaters
from ced-1 but not ced-8 or ced-1; ced-8 embryos
(fig. S15). Because 21% of ced-8 ventral cord cell
corpses had normal PtdSer exposure, additional
factors probably contribute to this process.
In short, the Xk-related proteins Xkr8 and
CED-8 promote caspase-dependent PtdSer ex-
posure during apoptosis. Based on the following
observations, Xkr8 and CED-8 probably act at a
late step in PtdSer exposure, possibly in phospho-
lipid scrambling: (i) Xkr8-deficient cells expose
PtdSer in response to Ca2+, indicating that Xkr8
is dispensable for steps before PtdSer exposure,
including PtdSer biogenesis and localization; (ii)
Xkr8 is directly activated by caspase cleavage, sug-
gesting Xkr8 does not function before the onset
of apoptosis; and (iii) Xkr8 and CED-8 are trans-
membrane proteins at the plasma membrane and,
therefore, are positioned to effect, or interact with
partners that effect, the externalization of PtdSer
during apoptosis.
Fig. 3. Activation of Xkr8 by caspase cleavage. (A and B) PLB-985 and transformants expressing
hXkr8-GFP or hXkr8 2DA-GFP were treated with STS and stained with Cy5–Annexin V (A). In (B), the cell
lysates were analyzed by Western blotting with anti-GFP and anti-ICAD antibodies. (C) WR-Fas and
transformants expressing GFP, mXkr8-GFP, or mXkr8 2DA-GFP were treated with FasL. Cell lysates were
analyzed by Western blotting with anti-GFP. (D) The membrane fraction of PLB-985 cells expressing
hXkr8-GFP (W) or the 2DA mutant (DA) was incubated with human caspases (C1 to C10, caspase-1 to
caspase-10) and analyzed by Western blotting with anti-GFP antibody.
Fig. 4. Promotion of PtdSer expo-
sure and cell-corpse engulfment by
mouse Xkr8 and C. elegans CED-8.
(A) MEFs from Xkr8+/− and Xkr8−/− em-
bryos were treated with STS or control
buffer for 8 hours and stained with
Cy5–Annexin V. (B) IFETs of the indi-
cated genotypes were treated with FasL
and stained with Cy5–Annexin V and
PI. (C) The number of floater cells per
egg (n) was counted for each genotype.
Error bars indicate SD. ***P < 0.0001
in a Student’s t test for each pairwise
comparison between ced-x and ced-8;
ced-x double mutants. (D) PtdSer was
detected using MFG-e8::Venus. Shown
is the cell corpse of P12.aap (arrow-
head), which undergoes apoptosis and
is engulfed by P12.pa (arrow). The death
of P12.aap is accompanied by PtdSer
exposure inWT but not in ced-8 (n1891)
animals. In addition, P12.pa, like other
C. elegans engulfing cells (23, 24), ex-
poses PtdSer on its outer plasma mem-
brane during engulfment. DIC, differential
interference contrast microscopy.
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Although intracellular concentrations of Ca2+
increase during apoptosis (19, 20), the involve-
ment of Ca2+ in apoptotic PtdSer exposure is
unclear (4), and our observations do not support a
generalization.We found that FasL-induced PtdSer
exposure was Ca2+-dependent in WR19L cells,
but not Ba/F3 cells, and that whenWR19L cells
were transformed with Xkr8, they lost the Ca2+
requirement for the apoptotic exposure of PtdSer.
These results, together with the constitutive ac-
tivity of overexpressed Xkr8 in Ba/F3 but not
other cells, suggest that Xkr8 might cooperate
with Ca2+-regulated proteins in some cell-specific
contexts.
The swift clearance of dead cells is essential
for maintaining homeostasis, and the masking of
PtdSer on apoptotic cells or the failure of the en-
gulfment system can cause autoimmune disorders
like systemic lupus erythematosus (3, 21). Our
finding that Xkr8 is epigenetically repressed in
cancer cells suggests a mechanistic link among
inflammation, autoimmunity, and cancer (22).
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Reprogramming of Intestinal Glucose
Metabolism and Glycemic Control
in Rats After Gastric Bypass
Nima Saeidi,1,2,3* Luca Meoli,1* Eirini Nestoridi,1* Nitin K. Gupta,1 Stephanie Kvas,1
John Kucharczyk,1 Ali A. Bonab,2 Alan J. Fischman,2 Martin L. Yarmush,2,3 Nicholas Stylopoulos1†
The resolution of type 2 diabetes after Roux-en-Y gastric bypass (RYGB) attests to the important role
of the gastrointestinal tract in glucose homeostasis. Previous studies in RYGB-treated rats have shown
that the Roux limb displays hyperplasia and hypertrophy. Here, we report that the Roux limb of
RYGB-treated rats exhibits reprogramming of intestinal glucose metabolism to meet its increased
bioenergetic demands; glucose transporter-1 is up-regulated, basolateral glucose uptake is enhanced,
aerobic glycolysis is augmented, and glucose is directed toward metabolic pathways that support tissue
growth. We show that reprogramming of intestinal glucose metabolism is triggered by the exposure
of the Roux limb to undigested nutrients. We demonstrate by positron emission tomography–computed
tomography scanning and biodistribution analysis using 2-deoxy-2-[18F]fluoro-D-glucose that
reprogramming of intestinal glucose metabolism renders the intestine a major tissue for glucose
disposal, contributing to the improvement in glycemic control after RYGB.
Roux-en-Y gastric bypass (RYGB) inducessubstantial and sustained weight loss andis a highly effective treatment for severe
obesity (1–3). The results of three recent prospective
studies suggest that RYGB is the best treatment op-
tion for obesity-related diabetes (4–6). Inter-
estingly, the improvement in glucose homeostasis
occurs early after the RYGBprocedure, before any
appreciable weight loss, and patients are often able
to discontinue their antidiabeticmedications before
hospital discharge (4, 5, 7, 8). The precise mech-
anisms underlying the resolution of diabetes after
RYGB have not been determined (3, 8–10).
Several studies in rodents and one study in
humans have previously described that the Roux
limb displays morphological changes, character-
ized by hypertrophy and hyperplasia after RYGB
(11–16). However, the importance of the mor-
phological adaptation of the Roux limb, in itself,
in the metabolic effects of RYGB remains largely
unknown. Because the construction of the Roux
limb is one of the fundamental components of the
RYGB procedure (Fig. 1A) (17, 18), we hypothe-
sized that the beneficial effect of RYGB on glu-
cose homeostasis may stem from changes in
the metabolism within this reconfigured jejunal
segment to meet the increased bioenergetic de-
mands of tissue growth and maintenance, pos-
sibly in response to its exposure to undigested
nutrients. To study the Roux limb, we performed
RYGB in rats (19). RYGB led to substantial and
sustained weight loss and improvement in glu-
cose metabolism in diet-induced obese (DIO)
rats, recapitulating the effects observed in hu-
mans (fig. S1, A to E). RYGB also improved
glycemic control in two nonobese, diabetic rodent
models with impaired insulin secretion: strep-
tozotocin (STZ)–induced diabetic and Goto-
Kakizaki (GK) rats (Fig. 1, B to D, and fig. S1,
F to I). We also observed intestinal remodeling,
characterized by increased intestinal mass due to
hyperplasia and hypertrophy, in the Roux limb of
RYGB-treated rats (figs. S2 to S4 and supple-
mentary text 1).
To test our hypothesis, we initially sought
to identify possible metabolic changes in the
Roux limb of RYGB-treated rats. We compared
its metabolic profile with the profile of correspond-
ing segments of the jejunum of sham-operated
rats, using a quantitative polar metabolomic pro-
filing platform. Themetabolomic profiling showed
increased concentrations of glucose-6-phosphate,
d-gluconate, 6-phospho-d-gluconate and nicotin-
amide adenine dinucleotide phosphate (NADP+)
in the Roux limb, suggesting that the oxidative
phase of the pentose phosphate pathway (PPP) is
stimulated (fig. S5, A and B, and table S1). The
changes in the metabolites of the nonoxidative
phase of thePPPdid not reach statistical significance,
1Center for Basic and Translational Obesity Research, Division
of Endocrinology, Boston Children’s Hospital, Harvard Medical
School, Boston, MA 02115, USA. 2Shriners Hospital for Children,
Boston, MA 02114, USA. 3Center for Engineering in Medicine,
Massachusetts General Hospital, Harvard Medical School, Boston,
MA 02114, USA.
*These authors contributed equally to this work.
†Corresponding author. E-mail: Nicholas.Stylopoulos@childrens.
harvard.edu
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Materials and Methods 
Cell Lines, Recombinant Proteins, Antibodies, and Materials 
Mouse interleukin-3 (IL-3)-dependent Ba/F3 cells (25) were maintained in RPMI-10% fetal 
calf serum (FCS, Gibco), 45 units/ml mouse IL-3, and 50 µM β-mercaptoethanol. Human PLB-985 
(26), Jurkat, Namalwa, and Raji cells were grown in RPMI1640-10% FCS and 50 µM β-
mercaptoethanol. Plat-E packaging cells (27) were grown in DMEM-10% FCS. Mouse IL-3 (28), 
and human FasL (29) were prepared as described. Rabbit anti-activated caspase-3 mAb was from 
Cell Signaling. Mouse anti-human ICAD mAb was from Medical & Biological Laboratories, and 
Alexa 488-labeled goat anti-rabbit IgG Abs were from Invitrogen. Staurosporine was provided by 
Kyowa Hakko Kirin.  
 
Construction of the cDNA Library, and Identification of Xkr8 
Using poly(A) RNA from Ba/F3-PS19 cells, cDNA was synthesized with random hexamers as 
primers, and a BstXI adaptor was attached as described (5). DNA fragments 1.0 to 2.5 kb in length 
were size-fractionated by electrophoresis through a 1% agarose gel and ligated into a BstXI-
digested pMXs vector (30). Approximately 1.3 x 106 clones were produced with E. coli DH10B 
cells (ElectroMax DH10B; Invitrogen) by electroporation. Using plasmid DNA from the cDNA 
library, retrovirus was produced in Plat-E cells, concentrated by centrifugation, and used to infect 
Ba/F3 cells as described (5). Cells treated with A23187 were stained on ice for 15 min with Cy5-
Annexin V (Biovision) and for 2 min with 5 µg/ml Propidium Iodide, and sorted with a FACSAria 
(BD Biosciences). The cDNA integrated into the retroviral vector was identified by PCR (5) as the 
Xkr8 cDNA. Real-time PCR indicated that the amount of Xkr8 mRNA in Ba/F3-PS19 is similar to 
that in the parental Ba/F3 cells, suggesting that the strong PtdSer exposure in Ba/F3-PS19 cells is 
due to the mutation introduced into TMEM16F gene (5). 
 
Expression Plasmids for Mouse and Human Xkr8, and Their Mutants 
The coding sequences for mXkr8 (GenBank NM_201368) and hXkr8 (GenBank NM_018053) 
were prepared by RT-PCR from Ba/F3 and Namalwa cells, respectively. The pMXs puro c-GFP 
was constructed by inserting the GFP sequence into pMXs puro. The Xkr8 cDNAs were then 
inserted into pMXs puro c-FLAG (5) or pMXs puro c-GFP to express proteins tagged with FLAG 
or GFP at the C-terminus. To generate the D351A/D354A (2DA) mutant of mXkr8, and the 
D352A/D355A (2DA) mutant of hXkr8, the mouse and human Xkr8 cDNAs were mutated by 
recombinant PCR (31) using primers carrying the mutated nucleotides. 
Primers used to prepare the mXkr8 and hXkr8 cDNA were as follows (in each primer, the 
BamHI or EcoRI recognition sequence is underlined): mXkr8, 5’-
ATATGGATCCATCATGCCTCTGTCCGTGCACCA-3’ and 5’-
ATATGAATTCGAGGACTCCATTCAGCTGCA-3’; hXkr8, 5’-
ATATGGATCCGCCATGCCCTGGTCGTCCCGCGG-3’ and 5’-
ATATGAATTCTCCCTTCACTGGCGAAGCAG-3’. Primers used to generate the D351A/D354A 
(2DA) mutants of mXkr8, and the D352A/D355A (2DA) mutants of hXkr8 were : mXkr8 2DA, 5’-
GGGACCCTGCCCTCGTGGCTGGGACCCTAG-3’, and 5’-
CTAGGGTCCCAGCCACGAGGGCAGGGTCCC-3’and hXkr8 2DA, 5’-
AAGCCCGACCCTGCCCAGGTAGCCGGGGCC-3’ and 5’-
GGCCCCGGCTACCTGGGCAGGGTCGGGCTT-3’.  
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shRNA 
Four shRNA expression plasmids for mXkr8 and scrambled shRNA in a pRS vector were 
purchased from OriGene. Among the four mXkr8 target sequences, the most effective was 5’-
GAATCTGTGCCATCGCCTTGTTCTCAGCT-3’. WR19L cells were transfected by 
electroporation, and stable transformants were selected in medium with 1.0 µg/ml puromycin, and 
subjected to cloning by limited dilution. The Xkr8 mRNA was quantified by real-time RT-PCR.  
 
Establishment of Xkr8 Knock-out Mice 
Xkr8 conditionally targeted mice were generated by Unitech as a custom order. In brief, a neo-loxP 
cassette carrying the phosphoglycerate kinase promoter-driven neomycin-resistance gene flanked 
by FRT sequences was inserted into intron 3 of the Xkr8 gene. A 1.0-kb fragment containing exon 3 
was replaced with a fragment carrying the corresponding sequence and a loxP sequence. The 
diphtheria toxin A-fragment driven by the thymidine kinase promoter was inserted at the 5’ end of 
the vector. Mouse Bruce-4 embryonic stem cells (32) were transfected with the targeting vector, 
and the G418-resistant clones were screened for homologous recombination by PCR. Positive 
clones were used to generate Xkr8+/NeoFRT mice, which were crossed with transgenic mice carrying 
cytomegalovirus enhancer-chicken b-actin hybrid promoter (CAG)-driven Cre recombinase gene 
(CAG-CRE)(33) or CAG-driven flippase variant (FLPe) gene (CAG-FLPe)(34). The resulting mice 
were backcrossed to the wild-type C57BL/6 to generate Xkr8+/- or Xkr8+/flox mice. Intercrosses of 
Xkr8+/- mice generated Xkr8-/- mice in a normal Mendelian ratio. All the mice were housed in a 
specific pathogen-free facility at Kyoto University, and all the animal experiments were carried out 
in accordance with protocols approved by Kyoto University. 
 
Mouse Embryonic Fibroblasts and Fetal Thymocyte Cell Lines 
Fibroblasts were prepared form E14.5 embryos of Xkr8+/- and Xkr8-/- mice, and cultured in DMEM 
containing 10% FCS. A fetal thymocyte cell line (IFET) was established by immortalizing fetal 
thymocytes with H-rasV12 and c-myc as described (35, 36). In brief, Xkr8+/flox mice were 
intercrossed, and thymocytes were obtained on embryonic day 14.5. Retrovirus carrying the genes 
for H-rasV12 and c-myc was produced in Plat-E cells with the pCX4 vector (37), and bound to 
RetroNectin-coated plates (Takara Bio) by centrifugation at 2,000 x g for 2-3 h. The thymocytes 
were attached to the retrovirus-coated plate by centrifugation at 400 x g for 5 min, and cultured in 
DMEM-10% FCS, 1 x non-essential amino acids, 10 mM Hepes- NaOH buffer (pH 7.4), 50 µM β-
mercaptoethanol, 5 ng/ml mouse IL-7 (38) (PeproTech), and GlutaMaxTM (Gibco). The resultant 
IFET cells were infected with Adeno-Cre (Adenovirus Cre/loxP, Takara Bio), and subjected to 
cloning by limited dilution. The TMEM16F-/- IFET cell line was described previously (6).  
 
Transformation of Human and Mouse Cells 
Retroviruses carrying a Xkr8 cDNA were produced by introducing the pMX-puro vector into 
Plat-E cells, concentrated by centrifugation, and used to infect Xkr8-/- IFET cells. Stable 
transformants were selected in medium containing 2.0 µg/ml puromycin, and the expression of 
recombinant protein was confirmed by Western blotting with an anti-Flag Ab (Clone M2, Sigma) 
or anti-GFP Ab (Clone JL8, Clontech). Mouse Fas cDNA (39) was introduced into IFET cells by 
retrovirus- mediated transformation, and its expression was confirmed by flow cytometry with the 
anti-mouse Fas mAb (Jo2) (40). Human PLB-985 and mouse WR19L cells were transformed by 
retrovirus infection with amphotropic retrovirus envelope or VSVγ envelope. In brief, retrovirus 
was generated by transfecting 293T cells with the pMXs retrovirus vector, pGP (Takara Bio) for 
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Gag and pol-fusion protein, and pE-ampho (Takara Bio) or pCMV-VSV-G-RSV-Rev (provided by 
Dr. H. Miyoshi, Riken). Virus in the culture supernatant was concentrated by centrifugation and 
used to transform cell lines. To express Xkr8-GFP, 293T cells were transfected with pMXs 
puroXkr8-GFP with Fugene 6 (Promega), and transformants were selected in medium containing 
1.0 µg/ml puromycin. 
 
Induction of Apoptosis, Treatment with Ca2+ ionophore, and Flow Cytometry 
Apoptosis was induced with FasL, staurosporine, or UV. In brief, 5 x 105 cells in 500 µl of 
medium were incubated at 37°C with 10-400 units/ml hFasL for 1.2-2.0 h or with 10 µM 
staurosporine for 1.5-8.0 h. For UV exposure, 1 x 106 cells in 2 ml of PBS were exposed to 500-
2000 J/m2 UV radiation (254 nm) in a StrataLinker (Stratagene), and incubated at 37°C for 1.5-2.0 
h in 4 ml of RPMI1640-10% FCS. The cell viability was assayed by WST-1 assay with 2-(4-
Iodophenyl)-3- (4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-1; 
Dojin Laboratories) and 1-Methoxy-5-methylphenazinium methylsulfate as described (41). To 
detect the apoptotic DNA fragmentation, DNA extracted from cells was analyzed by 
electrophoresis on 1.5% agarose gel. To detect active caspase-3, 1 x 106 cells were fixed at 37° for 
10 min in PBS containing 1% paraformaldehyde, washed with chilled PBS-0.5% BSA, and 
permeabilized by overnight incubation at -20°C in 90% methanol. Cells in 100 µl of PBS-0.5% 
BSA were then incubated with 200-fold-diluted rabbit anti-active caspase-3 at room temperature for 
30 min, followed by incubation for 30 min with 1,000- fold-diluted Alexa 488-labeled goat anti-
rabbit IgG. The cells were washed with PBS-0.5% BSA, filtered into the FACS tube, and analyzed 
by a FACSAria. To monitor A23187-induced PtdSer exposure, 5 x 105 cells in 500 µl of Annexin V 
staining buffer (10 mM Hepes-NaOH buffer [pH7.4] containing 140 mM NaCl and 2.5 mM CaCl2) 
were treated with 3.0-10 µM A23187, and analyzed with a FACSAria at 20°C.  
 
Assay for Phospholipid Scrambling Activity 
To detect phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) on the cell 
surface, cells were stained on ice for 15 min with 2500-5000-fold diluted Cy5-Annexin V 
(Biovision) or 800-fold diluted biotin-Ro09-0198 (42) followed by 1.0 µg/ml APC- streptavidin in 
Annexin V staining buffer in the presence of 5 µg/ml propidium iodide, and analyzed by a 
FACSAria or FACSCalibur (BD Biosciences). To assay the internalization of phosphatidylcholine 
(PtdCho) and sphingomyelin (SM), 1 x 106 cells in 0.5 ml of Hank’s Balanced Salt Solution 
(HBSS) containing 1 mM CaCl2 (HBSS-Ca) were incubated on ice for 7 min. An equal volume of 
200 nM 1-oleoyl-2-{6-[(7-nitro-2-1,3- benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-
phosphocholine (NBD-PC)(Avanti Polar Lipids), or N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]hexanoyl]-sphingosine-1- phosphocholine (NBD-SM) (Avanti Polar Lipids) in HBSS-Ca 
was added, and incubated at 20°C. Aliquots (150 µl) were mixed with 150 µl HBSS containing 5 
µg/ml fatty-acid free BSA (Sigma-Aldrich) and 500 nM Sytoxblue (Molecular Probes), and 
analyzed by FACSAria. 
 
Engulfment of Apoptotic Cells by Macrophages 
Engulfment of apoptotic cells by macrophages was assayed essentially as described previously 
(43). In brief, cells were treated with UV to induce apoptosis and labeled with 0.1 µg/ml pHrodo 
succinimidyl ester (pHrodo, Invitrogen). Thioglycollate-elicited peritoneal macrophages were 
prepared from mouse peritoneal cavity 4 days after injection of 2 ml of 3% thioglycollate, and 
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incubated with apoptotic cells at 37°C for 2 h. The pHrodo-positive population in CD11b+ 
macrophages was regarded as the cells engulfing apoptotic cells.  
 
Treatment with 5-aza-2’-deoxycytidine, and Bisulfite Genomic Sequencing 
To treat human PLB-985 cells with 5-aza-2’-deoxycytidine (DAC, Sigma-Aldrich), 1.0 x 106 
cells in 10 ml of RPMI-10% FCS were incubated with 0.5 µM DAC for up to 7 days. Since DAC is 
an unstable compound, the medium was changed every 24 h. After DAC treatment, the cells were 
divided into three portions: one for FACS to analyze the PtdSer exposure, one for real-time RT-
PCR for Xkr8 expression, and one for methylation-specific PCR analysis (12). For the bisulfite 
genomic sequencing, DNA was modified with bisulfite using a kit (MethyEasy Xceed, Human 
Genetic Signatures). In brief, 3 µg DNA was denatured at 37°C for 15 min in 0.3 M NaOH, and 
treated with sodium bisulfite according to the protocol provided by the supplier except that the 
incubation time was changed to 90 min. The modified DNA was denatured at 95°C for 20 min, and 
amplified by PCR using primers (TTAGGGATTAGAATGTGTTT and 
CCTATACAAATAACCCAACT). PCR was carried out with EpiTaq HS polymerase (Takara Bio), 
and the product was cloned into the pGEM-Teasy vector for sequencing.  
 
Real-time RT-PCR 
Total RNA was reverse-transcribed using Superscript III reverse-transcriptase (Invitrogen) or 
High Capacity RNA-to-cDNA™ kit (Applied Biosystems). Specific cDNA was amplified in a 
reaction mixture containing LightCycler®480 SYBR Green I Master (Roche Diagnostics), and the 
mRNA was quantified at the point where the LightCycler System detected the upstroke of the 
exponential phase of PCR accumulation with the linearized plasmid DNA as reference. Primers for 
real-time RT-PCR were: mXkr8, 5’-GCGACGCCACAGCTCACACT-3’ and 5’-
CCCCAGCAGCAGCAGGTTCC-3’; mGapdh, 5’-AGCAGGCATCTGAGGGCCCA-3’ and 5’-
GAGAGCAATGCCAGCCCCGG-3’; hXkr8, 5’-AGGCCGGGCCATCATCCACT-3’ and 5’-
TGCGCCTGTTCTGAGGCAGC-3’; and hβ-actin, 5’-GCATCCTCACCCTGAAGTAC-3’ and 5’-
CTTAATGTCACGCACGATTTC-3’.  
 
Caspase Treatment of Cell Lysates 
The membrane fraction was prepared from PLB-985 transformants expressing hXkr8-GFP or 
hXkr8 2DA-GFP as described (28) and solubilized in 20 mM Tris-HCl buffer (pH 7.2)-140 mM 
NaCl, 1% Triton X-100, 10% glycerol, and 1 mM (p-aminophenyl) methanesulfonyl fluoride 
(APMSF). After removing insoluble materials by centrifugation, the membrane proteins (20 µg) 
were incubated at 37°C for 1 h with 3 units of various recombinant human caspases (Biovision) in 
100 µl of 50 mM Hepes-NaOH (pH 7.4), 50 mM NaCl, 5% glycerol, 5 mM DTT, 10 mM EDTA, 
0.1 mM APMSF and 0.1% CHAPS, and analyzed by Western blotting. 
 
Western Blotting 
Cells were lysed in RIPA buffer (50 mM Hepes-NaOH buffer [pH 8.0], 1% NP-40, 0.1% SDS, 
0.5% sodium deoxycholate, 150 mM NaCl, and 10% protease inhibitor cocktail). The lysates were 
mixed with 5 x SDS sample buffer (200 mM Tris-HCl [pH 6.8], 10% SDS, 25% glycerol, 5% β-
mercaptoethanol, and 0.05% bromophenolblue), and incubated at room temperature for 1 h to 
detect Xkr8-GFP, or boiled for 5 min to detect other proteins. Proteins were separated by SDS-
PAGE on a 10-20% gradient gel (Bio Craft), and transferred to a PVDF membrane (Millipore). The 
membranes were probed with 3000-fold-diluted mouse anti-GFP mAb, 3000-fold-diluted mouse 
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anti-human ICAD mAb, or 3000-fold-diluted rabbit anti-active caspase-3 mAb followed by 
incubation with 1,000-fold-diluted HRP-conjugated goat anti-mouse or rabbit Igs (Dako). The 
peroxidase activity was detected by the Western Lightning®-ECL system (PerkinElmer).  
 
C. elegans Strains, Plasmids and Experimental Procedures 
C. elegans strains were cultured as described (44) and maintained at 20°C. The Bristol strain 
N2 was used as the wild-type strain. Mutations used are listed below:  
LGI:  ced-1(e1735, n2091).  
LGIII: ced-6(n1813), ced-7(n1892), ced-12(n3261).  
LGIV: ced-2(e1752), ced-3(n3692, n2424), ced-5(n1812), ced-10(n1993).  
LGX: ced-8(n1891, n1999, n2090), nIs106[Plin-11::gfp].  
unknown linkage: nIs398[Pdyn-1::mfg-e8::Venus, Pmyo-2::dsRed].  
Shed cells or floaters were counted in eggs between the 2-fold and 3.5-fold stages of 
development (approximately 450–600 min after the first cell division) using a Zeiss Axioskop 
wide-field microscope equipped with a 100x objective equipped and Nomarski differential 
interference contrast (DIC) optics as described (17). PtdSer exposure on the corpses was detected 
using secreted MFG-e8::Venus expressed from the transgene nIs398 (18). All images were 
acquired using OpenLab software (PerkinElmer) and modified for publication using ImageJ. 
 
 
     --------10--------20--------30--------40--------50--------60--------70--------80-------------------90-------100----- 
Mouse         MPLSVHHHVALDVVVGLVSILSFLLDLVADLWAVVQYVLLGRYLWAALVLVLLGQASVLLQLFSWLWLTADPTELHHSQLSRPF-----------LALLHLLQLGYLYRCLHGMHQ 
rat            MPLSVHPQVALDVVIGLVSTLSFLLDLVADLWAVVQYVLVGRYLWAALVVVLLGQASVLLQLFSWLWLTADPTELHQLQPSRRF-----------LALLHLLQLGYLYRCLHGMRQ 
human          MPWSSRGALLRDLVLGVLGTAAFLLDLGTDLWAAVQYALGGRYLWAALVLALLGLASVALQLFSWLWLRADPAGLHGSQPPRRC-----------LALLHLLQLGYLYRCVQELRQ 
Fugu     MRVMGQATISNYSWIDFVFSVIGVFTFFVDWGADVWVATEFYSRGDFFWFGLLVSLMVLSSVLVQMFSWFWLKYDRELPDVCRQSGGGTVLFGDRVQL-SWLLHVLQLGFLCRHISAIRQ 
medaka           MAVFTFSPLDFVFSCLGLPLFLADVVLDVLAVIDFYKEEAWVRLSVLLLLLVGSSVLIQVYSWKWYIGDGLDLKTRVESALKKG---------LKTLHVLQLGIYVRHLGVLEK 
Xenopus      MPACCPPRYRLLDLVFALGGTLTFLLDLGSDVWGALAYYRAGDVAWAALLIGFYGMASLVLQLHSWGWFWTDRRSGNIWELPRDPPHRAGSGSASTYTERGPGELNARESASCGCIH 
 
--110--------------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------- 
mouse    GLSMCYQEMPS-------ECDLAYADFLSLDISMLKLFESFLEATPQLTLVLAIVLQNGQAEYYQWFGISSSFLGISWALLDYHRSLRTCLPSKPRLGRSSSAIYFLWNLLLLGPRICAI 
rat      GLSMCCQEVPS-------ECDLAYADFLSLDISMLRLFESFLEATPQLTLVLAIVLQSGNAEYYQWFGISSSFLGISWALLDYHRSLRTCLPSKPRLGWCSSAVYFLWNLLLLGPRICAI 
human     GLLVWQQEEPS-------EFDLAYADFLALDISMLRLFETFLETAPQLTLVLAIMLQSGRAEYYQWVGICTSFLGISWALLDYHRALRTCLPSKPLLGLGSSVIYFLWNLLLLWPRVLAV 
Fugu      GFRVWWRQQEG----------SEYAVYLTHDLSMLRLIETFSESAPQLTLMVHVMLCTNRARTVQ-----------SWMVVDYHRSLRAFLPDKAKQGWGSSLIYFLWNFLLIAPRVAAL 
medaka    SVSGFCGKGSDS------QNSKDVAVELSHDLCMLHLIETFSESAPQIVLWLTIILQDGK------------------------------LDDSNQLSIISSIIHFLWNLLLLLSRLTAL 
Xenopus   SLEVGIAAYRSSENNPTYDRYQEYAYFLTHDISMMRLMETFLENTPQLILLLYIVLHRGTIYTFQYFSISISFISISWAILDYHQSLRLFLKDKQSMNILSSIIYFLWNLLLIFSRIVCI 
 
220-------230-------240-------250-------260-------270-------280-------290-------300-------310-----------320-------330---- 
mouse    ALFSAVFPYYVALHFFSLWLVLLFWIWLQGTNFMPDSKGEWLYRVTMALILYFSWFNVSGGRTRGRAVIHLIFIFSDSVLLVTTSWVTHGTWLP----SGISLLMWVTIGGACFFLGLAL 
rat     ATFSVVFPYCLALHFLSLWLVLLYWVWLQDTKFMPNSNGEWLYRVTVALILYFSWFNVSGGRTRGRATIHLGFILSDSVLLVTTSWVTDSTW------LPGGVLLWAALGGACFSLGLVL 
human   ALFSALFPSYVALHFLGLWLVLLLWVWLQGTDFMPDPSSEWLYRVTVATILYFSWFNVAEGRTRGRAIIHFAFLLSDSILLVATWVTHSSWLP-----SGIPLQLWLPVGCGCFFLGLAL 
 Fugu    ALFASVVGGFVAVHFLLLWCVFVMWAWLQGTEFMDSVCGEGLYRATVGIIWYFSWFNVAEGQTRGRSIIYHSFITTDGGILLLTWWCYRDPVQ-----TEPYGLALLVTLLFSYLLGLLF 
Medaka   ALFASVLPCFIFTHVFCCWMVFVLFAWRAQTDFMDDPWGERLYRATVALIWYFDWFNVFKKRTKKSALLYHSFILLDTCMLCGLWFWRMNTHPPQFVIPRPYADVMASSVVAVYILGLMV 
 Xenopus  TLFISVFHLWVALHFLLLWIAFFLWATWQSTDFMRNRILEHFFRATVAVILYFSWFNIADGRTIYRCIVYYCFITADSVILFMSWKIFKFPSI-----LDEYETYLLYVLAVFFPVGILF 
  
        ---340-------350---------------------------360-------370-------380-------390-------400------ 
mouse    RVIYYLWLHPSCSWD--------------------PDLVDGTLGLLSPHR----PPKLIYNRRATLLAENFFAKAKARAVLTEEVQLNGVL- 
  rat     RMIYYLRLHPSCSWE--------------------PDFVDGTLRLLPPER----PPKLIYNRRATRLAQNFFAKLKTQAALPQAVQLNGVL- 
human    RLVYYHWLHPSCCWKPD------------------PDQVDGARSLLSPE-----GYQLPQNRRMTHLAQKFFPKAKDEAASPVKG------- 
Fugu     KTVYYCCFHPTMRRPPA---------------RESSDLPDAEVTFRHFSIQDGAPSSPLLNRRMAAHAARFYSERRAVKNLGGVDAATSSPP 
Medaka    KALYYRFFHPKHNQDNLRGEDQNEVSGQNNDTRRERDETDGTMMMRMMVSSPAPLRQTQNGKKRMRMLAENFYS------------------ 
Xenopus   RVLYYLYLHPNLQ--------------KKKKKKEMYDEPDGLMSDANGYRLLKREPVMLKNPRIIQLSMQLM-------------------- 
 
 
 
Fig. S1. An alignment of the amino acid sequences of six vertebrate Xkr8 orthologs. The putative transmembrane regions are shaded blue, perfectly 
conserved amino acids are red, and the caspase-recognition sites are yellow.  
50                           
mouse Xkr8                                          MPLSVHHHVALDVVVGLVSILSFLLDLVADLWAVVQYVLLGRYLWAALVLVLLGQASVLLQLF 
CED-8       MFLKKHKSKLLLVPPRDEEQEDAGIVAVLTDRIPSVVLLVRWFDLFCFGFAMCSYALDFFSDIGIAIFHFWAGRYLSGSLVLAFALLPSVIINII 
CG32579                                MASAEQRTEVDALMMGPISKLSMLLTVVSILWRFVSICINWSLAYVYWMEESYGYCAWTIGSILVPMVVTSVI 
100                                                                              
mouse Xkr8    SWLWLTADPTELHHSQLSRP--------------------FLALLHLLQLGYLYRCLHGMHQGLSMCYQEMPSECDLAYADFLSL--DISMLKLF 
CED-8       SMVWMLDD--EMHWKRRAHPRRTGTFELNQKRFIPLSKMIVLCICQMGPLFWYYKALYYGWMFRKSSNENTDGEKRKCFSKMVEAERDATLLRFF 
CG32579     Y----------IHTLKSAHA--------GEKRILERG---VYSNAVISYLFRDVYVLNYAFKYSLAKERDDKQAEIEYYQKLMTEECNVSFVRLF 
150                                                                                                                  200                                           
mouse Xkr8    ESFLEATPQLTL---VLAIVLQN----GQAEYYQWFGISS---SFLGISWALLDYHRSLRTCLPSKPRLGRSSSAIYFLWNLLLLGPRICAIALF 
CED-8       EAFLESAPQLIIQGSIAASYFQNYYQTGTYPYWLYFQAASLLLSIISISWSVVVQNRSLRMIRDDKVNIWPHEAVLQFCWRFLTILARIITLVAL 
CG32579    DSFLESAPQKILQ---LAILLQSTLE------FTYYRHIALIVYFGNIAWCIQAYNHSNRLAQLDKHDIAAKGRFLQFLFLLCLTVSRTLCIAYV 
250                                                                                                   300                                
mouse Xkr8    SAVFPYYVA-LHFFSLWLVLLFWIWLQGTNFMPDSKGEWLYRVTMALILYFSWFNVSGGRTRGRAVIHLIFIFSDSVLLVTTSWVTHGTWLPSGI 
CED-8       VLIFGINVVPLISVHLLVTLVHVIFLQAIHIDACTHIEKLLLLINTFIHIFIPFNMVEGNTRWRYLTAYSVEFIEMMLVCWL----LPLSLNTFP 
CG32579     ASIFPIETLIICATLACFYGTIVFFVDSPMIAKSRPMNYSYCLCFGVVYLFIFTPVKDAPTKYKYAFYLTFCLLQNIIACAL------------Y 
350                                                                                                    400                     
mouse Xkr8    SLLMWVTIGGACFFLGLALRVIYYLWLHPSCSWDPDLVDGTLGLLSPHRPPKLIYNRRATLLAENFFAKAKARAVLTEEVQLNGVL    (401)  
CED-8       YIEKVQVGVPISFIAGIAIMMMYYQFFHPNRRQLIVTQSQEDLSLNVQKSVETLTPKLESSLEISGEQNTSQDLVSELLLDVEHEN    (458)  
CG32579     IPLYLATAIIALYIVGIVLLIIYYTYCHPNTVRTYF                                                                (352)  
 
 
Fig. S2. An alignment of amino acid sequences of mouse Xkr8, C. elegans CED-8, and Drosophila CG32579. Identical amino acids are red, and similar 
amino acids are pink. Similar amino acids are defined as residues belonging to one of the following groups: S, T, P, A, and G; N, D, E, and Q; H, R, and 
K; M, I, L and V; F, Y, and W. Putative transmembrane regions are underlined, and the caspase recognition site in mouse Xkr8 is indicated in green. The 
number at the end of sequence indicates the number of amino acids of each protein. 
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Fig. S3. 
Xkr8 and its GFP-fusion proteins. (A) The predicted topology of mammalian Xkr8 proteins. 
Putative transmembrane regions are numbered. (B) Representations of wild-type and caspase-
resistant (2DA) mutant forms of hXkr8 and mXkr8 fused to GFP. TM, transmembrane.  
  8 
           
Fig. S4 
FasL-induced activation of caspase-3. WR-Fas transformants expressing GFP, mXkr8-GFP or 
mTMEM16F-GFP were treated with FasL. The cell lysates were analyzed by western blotting with 
anti-active caspase-3 and anti-α-tubulin antibodies. 
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Fig. S5 
Real-time PCR quantification of mXkr8 mRNA abundance (relative to GAPDH mRNA) in WR-Fas 
clones transformed with plasmid DNA carrying mXkr8 shRNA or scrambled (Scr) shRNA. Two 
clones for each transformant were analyzed. Right, effect of mXkr8-shRNA on caspase-3 activation. 
For each WR-Fas transformation (Scr shRNA-expressing, mXkr8 shRNA-expressing, and mXkr8 
shRNA- plus hXkr8-expressing transformants), two independent samples were treated with FasL, 
lysed, analyzed by western blotting with anti-active caspase-3 and anti-α-tubulin antibodies. 
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Fig. S6 
Xkr8 does not affect most aspects of apoptotic cell death. Human PLB985 cells (parental) and their 
human Xkr8-transformants (+hXkr8) were treated with 10 mM staurosporine (STS) for 4 hr or left 
untreated (control). (A) Activation of caspase-3. Paraformaldehyde-fixed cells were permeabilized 
by treating with methanol and stained with rabbit anti-active caspase-3. The FACS profiles of 
control and STS-treated cells are represented by green and open areas, respectively. (B) DNA 
fragmentation. DNA was prepared from control and STS-treated cells, submitted to agarose gel 
electrophoresis, and stained with ethidium bromide. (C) Cell death. Cell death was assayed by the 
WST-1 method as described in Materials and Methods. (D) Cell shrinkage. The cells were analyzed 
by FACSAria. The FSC profiles represent cell size. 
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 IRF IRF -200  SP-1      SP-1 SP-1     SP-1 
  GCCTGCGAAGCGAAGGGCAGTCGGTCTTCAGGCCTAGCGGGCTTGGCTGGGCTGGGTCGGTGGACCCCTGGGCTGGCGG 
    -150    SP-1 SP-1  -100 SP-1 STAT 
  CGGGAGCAGAGCATCGAGCGGCTTTTAGCTGGGGTTCGGGCGGAGGACCTGGGACAACCGCGGGCCTCGCTCCTCCCCG 
  SP-1  SP-1 NF-kB  -50 SP-1 SP-1 NF-kB        SP-1 SP-1  +1 
  GACGGGGCGGGACGGGGAAGTCCCGCCCACCAGGCCCAGGCCCCGGGCCGCCCCGAGGGCTGCGCCCACCTCCTTCCTG 
 
 
C 
                                   -201                          -151                           -101                          -51                          -1 
 
 
Fig. S7. 
Methylation of the CpG islands in hXkr8 gene. (A) CpG islands in hXkr8 gene promoter. Open and 
filled boxes, 5’ non-coding and coding regions, respectively. Arrow, transcription start site. Each 
CpG is represented by a vertical bar. (B) The nucleotide sequence from -232 to +4 of the hXkr8 
gene. The 23 CpGs are shown in red, and predicted transcription-factor recognition sites are 
underlined. (C) Methylation status of the CpG islands. Each circle represents a CpG between 
positions -232 and +4, and the extent of methylation is represented by shading: black, 76-100%; 
grey, 26-75%; white, 0-25%.  
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Fig. S8. 
Characterization of the hXkr8-mediated scrambling of phospholipids. (A) Apoptotic cleavage of 
ICAD. PLB-985 cells and hXkr8-expressing transformants were treated with STS, and cell lysates 
were analyzed by western blotting with anti-ICAD. (B) Apoptotic exposure of PtdEtn. PLB-985 
and hXkr8-expressing transformants were treated with STS, stained with biotin-RO peptide and 
streptavidin-APC and PI, and analyzed by FACS. (C and D) Scrambling of PtdCho and SM in 
apoptotic cells. PLB-985 and hXkr8-expressing transformants were treated with STS and incubated 
with NBD-PC (C) or NBD-SM (D). Unincorporated lipids were extracted and analyzed by 
FACSAria at two minute time intervals. The fluorescence intensity in the SytoxBlue-negative 
fraction is shown in arbitrary units as the internalized NBD-PC or NBD-SM. 
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Fig. S9. 
hXkr8 does not alter Ca2+-dependent PtdSer exposure. PLB-985 and its hXkr8 transformants were 
treated at 20°C with 10 µM A23187 and stained with Cy5-labeled Annexin V. Annexin V-binding 
to the cells was monitored by flow cytometry at two minute intervals for 10 min. 
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Fig. S10 
Xkr8 mRNA abundance in different mouse tissues. Tissue-specific Xkr8 mRNA levels were 
determined by real-time RT-PCR and expressed relative to Gapdh mRNA.  
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Fig. S11. 
Gene structures of wild-type, floxed and deleted alleles of mXkr8 and the targeting vector. 
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Fig. S12. 
mXkr8 is not required for apoptosis-induced caspase-3 activation. (A) MEFs from Xkr8+/- and Xkr8-
/- embryos were treated with (+) or without (-) staurosporine (STS) for 8 h. Cell lysates were 
analyzed by western blotting using anti-active caspase-3 or anti-α-tubulin antibodies. (B) The 
Xkr8fl/fl, Xkr8-/-, mXkr8-transformed Xkr8-/-, and TMEM16F-/- IFETs expressing Fas were treated 
with FasL, stained with anti-active caspase-3, and analyzed with flow cytometry. The FACS 
profiles for the untreated (open) and FasL-treated cells (filled) are shown. The percentage of cells 
carrying the active caspase-3 is indicated. 
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Fig. S13. 
ced-8, the C. elegans homolog of mammalian Xkr8, promotes the engulfment of apoptotic cells. 
Shown are Nomarski DIC micrographs of (A) ced-1(e1735), (B) ced-8(n1891), and (C) ced-
1(e1735); ced-8(n1891) eggs that contain unengulfed apoptotic cells (termed “floaters” and 
indicated by arrowheads), which have detached from the developing embryo. 
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Fig. S14 
The pro-apoptotic caspase CED-3 is required for the generation of floater cells in the eggs of ced-8 
mutants and other mutants defective in cell-corpse engulfment.  Shown are the combined numbers 
of embryonic floater and shed cells that were counted in the eggs of each genotype. ced-3 mutations 
cause the extrusion of shed cells (17). Shed cells are morphologically different from floater cells 
generated by mutants defective in engulfment. We observed that ced-1 and ced-8 mutations 
synergistically cause the appearance of floater cells. By contrast, ced-3 mutations caused the 
appearance of shed cells and suppressed the generation of floaters in all tested genetic backgrounds, 
including ced-1; ced-8. Thus, ced-3 is epistatic to ced-1 and ced-8 with respect to the generation of 
shed cells and the suppression of floater cells, indicating that the floater cells of ced-1; ced-8 
mutants are dependent on apoptosis. For ease of presentation, we have indicated that ced-3 mutants 
generate shed cells (black bars) and that ced-1 and ced-8 mutants generate floaters (white bars). 
Error bars, standard deviations. 
 
  19 
 
Fig. S15. 
ced-8 promotes PtdSer exposure on the cell surface of floaters, the unengulfed apoptotic cell 
corpses that detach from engulfment-defective mutant embryos. Shown are Nomarski DIC and 
fluorescent micrographs of floaters (indicated by arrowheads) generated by (A) ced-1(e1735), (B) 
ced-8(n1891), and (C) ced-1(e1735); ced-8(n1891) mutants. PtdSer was detected using secreted 
MFG-e8::Venus expressed from the transgene nIs398. All floaters imaged were generated by 
embryos at the 1.5-fold stage of development or earlier. At later stages of embryonic development, 
ced-8 mutant floaters exhibit some PtdSer exposure, indicating that ced-8 mutations delay the 
process of PtdSer exposure and that C. elegans contains additional mechanisms of PtdSer exposure. 
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